In clinical trials, side effects tended to occur within the first weeks of starting therapy and with dose escalation, but they generally improved with time on a stable dose
So far the products seem effective and legit
Patients with blood vessel problems show much higher rates of retained stomach contents (15% versus 2%) [6]
The Potential of Compounded GLP-1 medication for Weight Loss Demonstrating remarkable potential in weight loss and appetite control, GLP-1 medication emerges as a promising pharmaceutical agent in the field of obesity management
Holding One Preprocedure Dose of GLP-1 Agonists Before Endoscopy, Clin Gastroenterol Hepatol (2026) [PubMed abstract] Preoperative evaluation
However, patients receiving GLP-1-RAs had also been treated longer, which could have affected the likelihood of reducing the medication for IIH